-
Innovation Ranking
Innovation Ranking – Radius Health Inc
Radius Health Inc (Radius Health), formerly NuVios Inc, is a biopharmaceutical company that develops and markets novel medicines for bone health, and endocrine diseases. The company’s marketed product includes abaloparatide injection, which is indicated for the treatment of postmenopausal women with osteoporosis. Its pipeline encompasses abaloparatide subcutaneous injection (SC) for high risk of fracture in men with osteoporosis; abaloparatide transdermal (TD) patch for postmenopausal women with osteoporosis; elacestrant (RAD1901) for estrogen-receptor (ER)-positive breast cancer; and RAD140 as an oral treatment...
-
Company Insights
Innovation and Patenting activity of Radius Health Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Radius Health Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Product Insights
NewAngelman Syndrome – Drugs In Development, 2024
Empower your strategies with our Angelman Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Angelman syndrome, an intricate genetic disorder primarily impacting the nervous system, manifests with distinctive features such as delayed development, intellectual disability, severe speech impairment, and ataxia, involving movement and balance issues. Recurrent seizures (epilepsy) and microcephaly, characterized by a small head size, are also prevalent in affected children. Recognizable at 6 to 12 months of age, delayed development intensifies in early childhood....
-
Product Insights
NewPost Menopausal Osteoporosis – Drugs In Development, 2024
Empower your strategies with our Post Menopausal Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Postmenopausal osteoporosis is the most common form of osteoporosis. It affects many women after menopause. Symptoms include back pain, loss of height, or spinal deformities such as stooped posture. Risk factors include age, gender, family history, bone structure, and body weight. Treatment includes hormone replacement therapy (HRT) and vitamin D analogues. The Post Menopausal Osteoporosis drugs in development market research report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVDX-3 in Bone Fracture
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVDX-3 in Bone Fracture report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVDX-3 in Bone Fracture Drug Details: NVD-X3 is under development for hard...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NVDX-3 in Degenerative Spondylolisthesis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NVDX-3 in Degenerative Spondylolisthesis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NVDX-3 in Degenerative Spondylolisthesis Drug Details: NVD-X3 is under development for hard...
-
Product Insights
NewOsteoporosis – Drugs In Development, 2024
Empower your strategies with our Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, and a bone fracture that occurs much more easily than...
-
Product Insights
Osteoporosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Osteoporosis Clinical Trial Report Overview A total of 2,254 osteoporosis clinical trials were conducted as of December 2023. The osteoporosis clinical trial report provides a comprehensive understanding of the osteoporosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       Europe ·       North America ·       ...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...